Skip to main content
Top
Published in: Annals of General Psychiatry 1/2018

Open Access 01-12-2018 | Review

A systematic review and meta-analysis of gender difference in epidemiology of HIV, hepatitis B, and hepatitis C infections in people with severe mental illness

Authors: Getinet Ayano, Mikiyas Tulu, Kibrom Haile, Dawit Assefa, Yodit Habtamu, Gebresilassie Araya, Zegeye Yohannis

Published in: Annals of General Psychiatry | Issue 1/2018

Login to get access

Abstract

Background

People with severe mental disorders (SMDs) are associated with increased risk of infectious disease including human immunodeficiency virus infection (HIV) and hepatitis viruses, such as hepatitis B virus (HBV), hepatitis C virus (HCV), and other types of hepatitis viruses because of high-risk behaviors compared to the general population. The prevalence of HIV in people with SMDs is higher in females than in males. Unlike HIV, the prevalence of HBV and HCV is higher in males than in females. This study aimed to carry out a systematic review and meta-analysis to determine the prevalence and estimated gender difference in the risk of HIV, HBV, and HCV in people with SMD.

Methods

Literature search was performed using the electronic databases PubMed, EMBASE, and Scopus. Publications were screened according to predefined inclusion criteria. A qualitative and quantitative analysis was undertaken for this systematic review. Eighteen materials published from 1993 to 2017 were included in the qualitative and quantitative analysis. Random-effect model was used to calculate weighted prevalence, odds ratio (OR), and corresponding 95% confidence interval (CI).

Results

12,290 citations were identified and 18 articles including 11,175 participants were included. The results of our meta-analysis show that the prevalence of HIV, HBV, and HCV in people with SMD was 7.59% (95% CI 4.82–11.75), 15.63% (95% CI 7.19–30.69), and 7.21% (95% CI 4.44–11.50), respectively. The prevalence of HIV was higher in women (8.25%) than men (7.04%), but the prevalence of HBV and HCV was higher in men than women (18.91% versus 12.02% and 9.16% versus 5.43% for HBV and HCV in men versus women, respectively). A meta-analysis of included studies demonstrated a significantly increased risk of HBV (OR 1.72; 95% CI 1.17–2.53) and HCV (OR 2.01; 95% CI 1.16–3.20) infections in men compared to women in people with SMD. However, no significant association was observed between gender and HIV. The funnel plot and Egger’s regression tests provided no evidence of substantial publication bias in the prevalence and gender difference in association for HIV, HBV, and HCV in people with SMD.

Conclusions

In our review, the prevalence of HIV, HBV, and HCV was high. The prevalence of HBV is significantly higher than HIV and HCV. There was a significantly increased risk of HBV and HCV infections in men compared to women. No significant association was observed between gender and HIV. People with SMDs warrant greater emphasis in efforts to identify and treat HIV, HBV and HCV.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, Butterfield MI, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health. 2001;91(1):31.CrossRefPubMedPubMedCentral Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, Butterfield MI, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health. 2001;91(1):31.CrossRefPubMedPubMedCentral
2.
go back to reference Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S, Ketema F, et al. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry. 2003;44(4):293–302.CrossRefPubMed Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S, Ketema F, et al. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry. 2003;44(4):293–302.CrossRefPubMed
3.
go back to reference Campos LN, Guimarães MDC, Carmo RA, Melo APS, Oliveira HNd, Elkington K, et al. HIV, syphilis, and hepatitis B and C prevalence among patients with mental illness: a review of the literature. Cadernos de saúde pública. 2008;24:s607–20.CrossRefPubMed Campos LN, Guimarães MDC, Carmo RA, Melo APS, Oliveira HNd, Elkington K, et al. HIV, syphilis, and hepatitis B and C prevalence among patients with mental illness: a review of the literature. Cadernos de saúde pública. 2008;24:s607–20.CrossRefPubMed
4.
go back to reference Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77.CrossRef Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77.CrossRef
5.
go back to reference HIV/AIDS JUNPo. Global report 2012: UNAIDS report on the global AIDS epidemic. UN; 2012. HIV/AIDS JUNPo. Global report 2012: UNAIDS report on the global AIDS epidemic. UN; 2012.
6.
go back to reference Hofstraat S, Falla A, Duffell E, Hahné S, Amato-Gauci A, Veldhuijzen I, et al. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiol Infect. 2017;145(14):2873–85.CrossRefPubMedPubMedCentral Hofstraat S, Falla A, Duffell E, Hahné S, Amato-Gauci A, Veldhuijzen I, et al. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiol Infect. 2017;145(14):2873–85.CrossRefPubMedPubMedCentral
7.
go back to reference Hung C-C, Loh E-W, Hu T-M, Chiu H-J, Hsieh H-C, Chan C-H, et al. Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions. J Chin Med Assoc. 2012;75(6):275–80.CrossRefPubMed Hung C-C, Loh E-W, Hu T-M, Chiu H-J, Hsieh H-C, Chan C-H, et al. Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions. J Chin Med Assoc. 2012;75(6):275–80.CrossRefPubMed
8.
go back to reference Singh D, Berkman A, Bresnahan M. Seroprevalence and HIV-associated factors among adults with severe mental illness: a vulnerable population. SAMJ S Afr Med J. 2009;99(7):523–7.PubMed Singh D, Berkman A, Bresnahan M. Seroprevalence and HIV-associated factors among adults with severe mental illness: a vulnerable population. SAMJ S Afr Med J. 2009;99(7):523–7.PubMed
9.
go back to reference Said W, Saleh R, Jumaian N. Prevalence of hepatitis B virus among chronic schizophrenia patients. East Mediterr Health J. 2001;7:526–30.PubMed Said W, Saleh R, Jumaian N. Prevalence of hepatitis B virus among chronic schizophrenia patients. East Mediterr Health J. 2001;7:526–30.PubMed
10.
go back to reference Di Nardo V, Petrosillo N, Ippolito G, Bonaventura ME, Puro V, Chiaretti B, et al. Prevalence and incidence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among personnel and patients of a psychiatric hospital. Eur J Epidemiol. 1995;11(2):239–42.CrossRefPubMed Di Nardo V, Petrosillo N, Ippolito G, Bonaventura ME, Puro V, Chiaretti B, et al. Prevalence and incidence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among personnel and patients of a psychiatric hospital. Eur J Epidemiol. 1995;11(2):239–42.CrossRefPubMed
11.
go back to reference Rosenberg SD, Drake RE, Brunette MF, Wolford GL, Marsh BJ. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. Aids. 2005;19:S26–33.CrossRefPubMed Rosenberg SD, Drake RE, Brunette MF, Wolford GL, Marsh BJ. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. Aids. 2005;19:S26–33.CrossRefPubMed
12.
go back to reference Lagios K, Deane FP. Severe mental illness is a new risk marker for blood-borne viruses and sexually transmitted infections. Aust N Z J Public Health. 2007;31(6):562–6.CrossRefPubMed Lagios K, Deane FP. Severe mental illness is a new risk marker for blood-borne viruses and sexually transmitted infections. Aust N Z J Public Health. 2007;31(6):562–6.CrossRefPubMed
13.
go back to reference Collins PY, Berkman A, Mestry K, Pillai A. HIV prevalence among men and women admitted to a South African public psychiatric hospital. AIDS Care. 2009;21(7):863–7.CrossRefPubMedPubMedCentral Collins PY, Berkman A, Mestry K, Pillai A. HIV prevalence among men and women admitted to a South African public psychiatric hospital. AIDS Care. 2009;21(7):863–7.CrossRefPubMedPubMedCentral
14.
go back to reference Butterfield MI, Bosworth HB, Meador KG, Stechuchak KM, Essock SM, Osher FC, et al. Gender differences in hepatitis C infection and risks among persons with severe mental illness. Psychiatr Serv (Washington, DC). 2003;54(6):848–53.CrossRef Butterfield MI, Bosworth HB, Meador KG, Stechuchak KM, Essock SM, Osher FC, et al. Gender differences in hepatitis C infection and risks among persons with severe mental illness. Psychiatr Serv (Washington, DC). 2003;54(6):848–53.CrossRef
15.
go back to reference Reviews UoYCf, Dissemination. Systematic reviews: CRD’s guidance for undertaking reviews in health care. York: University of York, Centre for Reviews & Dissemination; 2009. Reviews UoYCf, Dissemination. Systematic reviews: CRD’s guidance for undertaking reviews in health care. York: University of York, Centre for Reviews & Dissemination; 2009.
16.
go back to reference Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.CrossRefPubMedPubMedCentral Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.CrossRefPubMedPubMedCentral
17.
go back to reference Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.CrossRefPubMed Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.CrossRefPubMed
18.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed
19.
go back to reference Borenstein M, Hedges LV, Higgins J, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111.CrossRefPubMed Borenstein M, Hedges LV, Higgins J, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111.CrossRefPubMed
20.
go back to reference Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ Br Med J. 2003;327(7414):557.CrossRef Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ Br Med J. 2003;327(7414):557.CrossRef
21.
go back to reference Empfield M, Cournos F, Meyer I, McKinnon K, Horwath E, Silver M, et al. HIV seroprevalence among homeless patients admitted to a psychiatric inpatient unit. Am J Psychiatry. 1993;150(1):47.CrossRefPubMed Empfield M, Cournos F, Meyer I, McKinnon K, Horwath E, Silver M, et al. HIV seroprevalence among homeless patients admitted to a psychiatric inpatient unit. Am J Psychiatry. 1993;150(1):47.CrossRefPubMed
22.
go back to reference Silberstein C, Galanter M, Marmor M, Lifshutz H, Krasinski K, Franco H. HIV-1 among inner city dually diagnosed inpatients. Am J Drug Alcohol Abuse. 1994;20(1):101–13.CrossRefPubMed Silberstein C, Galanter M, Marmor M, Lifshutz H, Krasinski K, Franco H. HIV-1 among inner city dually diagnosed inpatients. Am J Drug Alcohol Abuse. 1994;20(1):101–13.CrossRefPubMed
23.
go back to reference Kilbourne AM, Cornelius JR, Han X, Pincus HA, Shad M, Salloum I, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6(5):368–73.CrossRefPubMed Kilbourne AM, Cornelius JR, Han X, Pincus HA, Shad M, Salloum I, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6(5):368–73.CrossRefPubMed
24.
go back to reference Cournos F, Horwath E, Guido J, McKinnon K, Hopkins N. HIV-1 infection at two public psychiatric hospitals in New York City. Aids Care. 1994;6(4):443–52.CrossRefPubMed Cournos F, Horwath E, Guido J, McKinnon K, Hopkins N. HIV-1 infection at two public psychiatric hospitals in New York City. Aids Care. 1994;6(4):443–52.CrossRefPubMed
25.
go back to reference Susser E, Valencia E, Conover S. Prevalence of HIV infection among psychiatric patients in a New York City men’s shelter. Am J Public Health. 1993;83(4):568–70.CrossRefPubMedPubMedCentral Susser E, Valencia E, Conover S. Prevalence of HIV infection among psychiatric patients in a New York City men’s shelter. Am J Public Health. 1993;83(4):568–70.CrossRefPubMedPubMedCentral
26.
go back to reference Stewart DL, Zuckerman CJ, Ingle JM. HIV seroprevalence in a chronically mentally ill population. J Natl Med Assoc. 1994;86(7):519.PubMedPubMedCentral Stewart DL, Zuckerman CJ, Ingle JM. HIV seroprevalence in a chronically mentally ill population. J Natl Med Assoc. 1994;86(7):519.PubMedPubMedCentral
27.
go back to reference Maling S, Todd J, Van der Paal L, Grosskurth H, Kinyanda E. HIV-1 seroprevalence and risk factors for HIV infection among first-time psychiatric admissions in Uganda. AIDS Care. 2011;23(2):171–8.CrossRefPubMed Maling S, Todd J, Van der Paal L, Grosskurth H, Kinyanda E. HIV-1 seroprevalence and risk factors for HIV infection among first-time psychiatric admissions in Uganda. AIDS Care. 2011;23(2):171–8.CrossRefPubMed
28.
go back to reference Lundberg P, Nakasujja N, Musisi S, Thorson AE, Cantor-Graae E, Allebeck P. HIV prevalence in persons with severe mental illness in Uganda: a cross-sectional hospital-based study. Int J Mental Health Syst. 2013;7(1):20.CrossRef Lundberg P, Nakasujja N, Musisi S, Thorson AE, Cantor-Graae E, Allebeck P. HIV prevalence in persons with severe mental illness in Uganda: a cross-sectional hospital-based study. Int J Mental Health Syst. 2013;7(1):20.CrossRef
29.
go back to reference Tharyan P, Ramalingam S, Kannangai R, Sridharan G, Muliyil J, Tharyan A. Prevalence of HIV infection in psychiatric patients attending a general hospital in Tamil Nadu, south India. AIDS Care. 2003;15(2):197–205.CrossRefPubMed Tharyan P, Ramalingam S, Kannangai R, Sridharan G, Muliyil J, Tharyan A. Prevalence of HIV infection in psychiatric patients attending a general hospital in Tamil Nadu, south India. AIDS Care. 2003;15(2):197–205.CrossRefPubMed
30.
go back to reference Esquivel CA, Valenzuela MÁA, Suárez MFM, Andrade FE. Hepatitis B virus infection among inpatients of a psychiatric hospital of Mexico. Clin Pract Epidemiol Mental Health. 2005;1(1):10.CrossRef Esquivel CA, Valenzuela MÁA, Suárez MFM, Andrade FE. Hepatitis B virus infection among inpatients of a psychiatric hospital of Mexico. Clin Pract Epidemiol Mental Health. 2005;1(1):10.CrossRef
31.
go back to reference Boisier P, Ouwe Missi Oukem-Boyer O, Amadou Hamidou A, Sidikou F, Ibrahim M, Elhaj Mahamane A, et al. Nationwide HIV prevalence survey in general population in Niger. Tropical Med Int Health. 2004;9(11):1161–6.CrossRef Boisier P, Ouwe Missi Oukem-Boyer O, Amadou Hamidou A, Sidikou F, Ibrahim M, Elhaj Mahamane A, et al. Nationwide HIV prevalence survey in general population in Niger. Tropical Med Int Health. 2004;9(11):1161–6.CrossRef
32.
go back to reference Amiri FB, Mostafavi E, Mirzazadeh A. HIV, HBV and HCV coinfection prevalence in Iran—a systematic review and meta-analysis. PLoS ONE. 2016;11(3):e0151946.CrossRef Amiri FB, Mostafavi E, Mirzazadeh A. HIV, HBV and HCV coinfection prevalence in Iran—a systematic review and meta-analysis. PLoS ONE. 2016;11(3):e0151946.CrossRef
34.
35.
go back to reference Martin NK, Vickerman P, Grebely J, Hellard M, Hutchinson SJ, Lima VD, et al. Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 2013;58(5):1598–609.CrossRefPubMedPubMedCentral Martin NK, Vickerman P, Grebely J, Hellard M, Hutchinson SJ, Lima VD, et al. Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 2013;58(5):1598–609.CrossRefPubMedPubMedCentral
36.
go back to reference Hagan H, Pouget ER, Des Jarlais DC. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis. 2011;204(1):74–83.CrossRefPubMedPubMedCentral Hagan H, Pouget ER, Des Jarlais DC. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis. 2011;204(1):74–83.CrossRefPubMedPubMedCentral
37.
go back to reference Organization WH. Guidance on prevention of viral hepatitis B and C among people who inject drugs. Geneva: World Health Organization; 2012. Organization WH. Guidance on prevention of viral hepatitis B and C among people who inject drugs. Geneva: World Health Organization; 2012.
38.
go back to reference Bosques-Padilla FJ, Vázquez-Elizondo G, Villaseñor-Todd A, Garza-González E, Gonzalez-Gonzalez JA, Maldonado-Garza HJ. Hepatitis C virus infection in health-care settings: medical and ethical implications. Ann Hepatol. 2010;9:132–40.PubMed Bosques-Padilla FJ, Vázquez-Elizondo G, Villaseñor-Todd A, Garza-González E, Gonzalez-Gonzalez JA, Maldonado-Garza HJ. Hepatitis C virus infection in health-care settings: medical and ethical implications. Ann Hepatol. 2010;9:132–40.PubMed
39.
go back to reference Gourley SA, Kuang Y, Nagy JD. Dynamics of a delay differential equation model of hepatitis B virus infection. J Biol Dyn. 2008;2(2):140–53.CrossRefPubMed Gourley SA, Kuang Y, Nagy JD. Dynamics of a delay differential equation model of hepatitis B virus infection. J Biol Dyn. 2008;2(2):140–53.CrossRefPubMed
Metadata
Title
A systematic review and meta-analysis of gender difference in epidemiology of HIV, hepatitis B, and hepatitis C infections in people with severe mental illness
Authors
Getinet Ayano
Mikiyas Tulu
Kibrom Haile
Dawit Assefa
Yodit Habtamu
Gebresilassie Araya
Zegeye Yohannis
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue 1/2018
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/s12991-018-0186-2

Other articles of this Issue 1/2018

Annals of General Psychiatry 1/2018 Go to the issue